The Biomedical Applications of Graphene and Graphene-Related Materials

Dear Colleagues,

In recent decades, a great deal of attention has been paid to the pharmaceutical and biomedical applications of graphene oxide and graphene quantum dots. The use of such materials facilitates the development of drug formulations by mixing solutions of graphene quantum dots and drugs, and can be used to improve the dissolution of low-molecular-weight hydrophobic drugs. Due to the ease of formulating pharmaceutical products by a simple process of mixing drugs with these substances, as well as their favorable biocompatibility and the possibility of numerous applications, they can be used in medicine and pharmacy to control dual drug release, the dissolution of insoluble drugs, and the controlled release of drugs and large biological molecules such as proteins and genes. Graphene-based nanostructures and nanohybrids have attracted increasing attention in recent years due to their two-dimensional structures, high surface areas, good biocompatibility, low mass density, and unique electrical properties. One of the most exciting application areas of graphene and graphene oxide is in the biomedical engineering field. Still, there is work to be done on the biomedical applications of graphene and graphene oxide. For instance, the synthesis of novel graphene- or graphene oxide-based nanohybrids and nanocomposites for potential biomedical applications could be developed; the feasibility and performance of graphene-based nanohybrids for biomedical applications should carefully be evaluated; and the bio-reaction processes and interaction mechanisms of graphene and graphene oxide with cells and tissues could be understood more deeply. This Special Issue is expected to gather contributions from corresponding works on new methods, new structures, new materials, and new bio-applications.

We are looking forward to your contributions to this Special Issue.

Dr. Seyyed Mojtaba Mousavi
Dr. Seyyed Alireza Hashemi
Dr. Wei-Hung Chiang
Dr. Ahmad Gholami
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• bioactive supramolecular
• hydrogels
• controlled drug release
• biomedical